Quell Therapeutics

Quell Therapeutics to Participate at Upcoming Healthcare Investor Conferences

6 November 2024– London, UK – Quell Therapeutics Ltd (“Quell”), a world leader in developing engineered T-regulatory (Treg) cell therapies for serious medical conditions driven by the immune system, announces that management will participate on a panel at the Guggenheim Healthcare Innovation Conference being held November 11-13 in Boston, MA, USA and will be attending...
Quell Therapeutics Ltd, Translation & Innovation Hub, 84 Wood Lane, London, W12 OBZ

0207 096 9012